Why Your Prescription Cost More This Year Than Last: The Forces Quietly Driving Up Drug Prices Across Canada

The Quiet Shock at the Pharmacy Counter

For many Canadians, the moment of surprise arrives without warning. A prescription that cost a predictable amount throughout 2023 suddenly carries a noticeably higher price tag in 2024 or 2025. No letter arrived in the mail. No pharmacist offered an explanation unprompted. The number simply changed, and patients are left wondering why.

This is not an isolated experience. Across provinces, Canadians filling both brand-name and generic prescriptions are absorbing price increases that have compounded year over year. Understanding why this is happening—and what levers patients can actually pull—begins with looking at the systems that govern pharmaceutical pricing in this country.

How Drug Prices Are Actually Set in Canada

Canada operates under a regulated pricing framework for patented medications, overseen by the Patented Medicine Prices Review Board (PMPRB). In theory, this body caps what manufacturers can charge for patented drugs by benchmarking Canadian prices against those in comparable countries. In practice, the system has faced significant criticism for being slow to respond to market realities and for leaving considerable room for price movement within permitted bands.

For generic medications—which represent the majority of prescriptions dispensed in Canada—pricing is largely governed at the provincial level through drug benefit formularies and negotiated agreements between provinces and manufacturers. These agreements are renegotiated periodically, and when they shift, the downstream effects reach patients relatively quickly.

The critical point is this: neither system offers patients real-time transparency. Prices can change, and patients are rarely notified proactively.

The Supply Chain Factor

The post-pandemic period reshaped global pharmaceutical supply chains in ways that continue to reverberate. Active pharmaceutical ingredients (APIs), the chemical building blocks of most medications, are predominantly manufactured in a small number of countries. When shipping costs spiked, when manufacturing facilities faced regulatory scrutiny, or when raw material costs climbed, those expenses were eventually passed along the supply chain.

Canada's pharmaceutical import dependency makes it particularly vulnerable to these dynamics. A disruption in the production of a single API can affect the price of dozens of finished medications. Drug shortages, which Canadians have experienced with notable frequency since 2022, are often a symptom of the same upstream pressures that also drive prices upward when supply normalises but costs do not fall.

Currency Fluctuations and the Canadian Dollar

The Canadian dollar's performance against the US dollar and the euro has a direct and underappreciated influence on domestic drug prices. Because a significant proportion of pharmaceutical products are sourced internationally and priced in foreign currencies, a weaker Canadian dollar effectively increases the cost of imported medications before a single additional regulatory or distribution fee is applied.

In periods when the loonie weakens—as it did during portions of 2023 and 2024—importers, wholesalers, and distributors absorb higher costs that are subsequently reflected in retail prices. Patients rarely see an explicit line item explaining this mechanism, but it is a genuine and measurable contributor to year-over-year price increases.

Which Medication Categories Are Seeing the Steepest Increases in 2024–2025

Not all drug categories are affected equally. Based on trends observed across Canadian dispensing data and provincial formulary updates, several categories have drawn particular attention:

• Diabetes medications, including GLP-1 receptor agonists, have seen significant demand-driven price pressure as off-label use for weight management has expanded globally, tightening supply.
• Cardiovascular medications, particularly newer anticoagulants and cholesterol-lowering agents, have experienced moderate but consistent price creep as patent landscapes shift.
• Mental health and neurological prescriptions, including certain antidepressants and ADHD medications, have faced both supply constraints and increased demand, a combination that reliably pushes prices upward.
• Respiratory medications, including inhalers for asthma and COPD, have seen price adjustments tied to device reformulation requirements and environmental compliance changes.

Patients managing chronic conditions in any of these categories are disproportionately affected, since they fill prescriptions repeatedly and cannot simply delay treatment.

What Patients Can Actually Do

The good news is that patients are not entirely without options. Several practical strategies can meaningfully reduce out-of-pocket costs even in an environment of rising prices.

Ask about generic equivalents explicitly. Even when a generic has been available for years, it is not always offered automatically. Asking your pharmacist directly whether a lower-cost equivalent exists for your prescription is a simple step that consistently yields results.

Request a price comparison before dispensing. In Canada, pharmacies are not universally required to provide price transparency before dispensing. However, patients are entitled to ask what a medication will cost before it is filled. This is especially important for those without comprehensive drug coverage.

Review your provincial drug benefit eligibility. Provincial drug benefit programmes have different income thresholds, age criteria, and qualifying conditions. Many eligible Canadians are not enrolled. Spending ten minutes confirming your eligibility with your province's health authority or a licensed pharmacist could result in substantial savings.

Consider a licensed online pharmacy with transparent pricing. Online pharmacies licensed to operate in Canada—like CanadaRx Health—are required to maintain the same dispensing standards as brick-and-mortar locations while often operating with lower overhead. This can translate into more competitive pricing, particularly for maintenance medications filled on a recurring basis. Licensed pharmacists remain available for consultation, ensuring safety is never compromised in pursuit of cost savings.

Use manufacturer patient support programmes. For brand-name medications without generic alternatives, many pharmaceutical manufacturers operate co-pay assistance or patient support programmes. These are not widely advertised but can significantly offset costs for qualifying patients.

The Importance of Price Transparency in Your Pharmacy Relationship

A well-functioning relationship with your pharmacy should include the ability to have frank conversations about cost. If your current pharmacy does not proactively discuss pricing options, it may be worth evaluating whether the relationship is serving your needs fully.

Licensed pharmacists are trained not only in the clinical dimensions of medication management but also in navigating formularies, identifying substitution opportunities, and understanding coverage nuances. Engaging them on cost is not an awkward or unusual request—it is a legitimate component of patient care.

At CanadaRx Health, our pharmacists are available to review your current prescription profile and identify whether lower-cost alternatives, dosage optimisations, or coverage adjustments could reduce your annual medication expenditure without compromising therapeutic outcomes.

A Systemic Problem That Requires Patient Awareness

The forces driving prescription price increases in Canada are structural. Regulatory frameworks, global supply chains, and currency markets do not respond quickly to individual patient pressure. What patients can control, however, is how informed they are and how actively they engage with the systems available to them.

Knowing that prices can and do change year over year—and understanding the mechanisms behind those changes—positions you to ask better questions, make more informed decisions, and access the resources that exist to help manage those costs. In a healthcare landscape that does not always communicate transparently, that knowledge is genuinely valuable.